City Clinical Hospital №52

Moscow 123182

0 studies enrolling now · 7 studies all time

What they study most

COVID-19 Pneumonia, Chronic Kidney Disease (CKD) Stage 5, Diabetes Mellitus, Type 2, Hypertrophy, Left Ventricular, Multiple Myeloma, Obesity, Overweight, Polycystic Kidney Disease, Autosomal Dominant, Vaginitis, Vulvovaginitis

Studies at this site

• A Research Study to Compare Two Types of Insulin, a New Weekly Insulin, Insulin Icodec and an Available Daily Insulin, Insulin Glargine, Both in Combination With Mealtime Insulin, in People With Type 2 Diabetes Who Use Daily Insulin and Mealtime Insulin (ONWARDS 4) — Completed
• Semaglutide Effects on Heart Disease and Stroke in Patients With Overweight or Obesity — Completed
• Safety and Efficacy of Pomalidomide, Bortezomib and Low-dose Dexamethasone in Subjects With Relapsed or Refractory Multiple Myeloma — Completed
• A Study to Evaluate the Efficacy and Safety of Remdesivir Plus Tocilizumab Compared With Remdesivir Plus Placebo in Hospitalized Participants With Severe COVID-19 Pneumonia — Completed
• Tolvaptan Phase 3 Efficacy and Safety Study in Autosomal Dominant Polycystic Kidney Disease (ADPKD) — Completed
• Vaginal Infection Study — Completed
• The PRIMO II Study: Paricalcitol Injection Benefits in Renal Failure Induced Cardiac Morbidity in Subjects With Chronic Kidney Disease (CKD) Stage 5 — Stopped early